BILLS-113hr1531ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (12)
15 2010
02:15 Apr 19
1531 IH
years
1974
90 days
VerDate Mar
1ST SESSION H. R. 1531
2012
2013
1986
APRIL 12, 2013
EVENT (1)
the ‘‘Breast Cancer Patient
FAC (7)
PO 00000
Frm 00017
PO 00000
Frm 00007
PO 00000
Frm 00012
PO 00000
Frm 00010
PO 00000
Frm 00002
PO 00000
Frm 00001
PO 00000
Frm 00019
GPE (17)
New York
Georgia
Ohio
1531 IH
California
Indiana
Iowa
States
ISRAEL
Texas
Arizona
Connecticut
Maine
Alaska
the United States of America
North Carolina
Florida
LOC (1)
IH
ORG (22)
SEC
nates
EXTERNAL
CONGRESS
the Committee on Energy and Commerce
IH
INSURANCE COVERAGE.—Section
U.S.C.
HOLT
the National Cancer Institute
the American Cancer Society
State
PENALTIES.—A
House of Representa-
Ways and Means and Education
THE HOUSE OF REPRESENTATIVES
the Internal Revenue Code
Senate
SABLAN
the Patient Protection and Affordable
19
8) Research
PERSON (50)
VerDate Mar
CONNOLLY
BROWN
RUSH
BORDALLO
MOORE
DEGETTE
DELAURO
SCHIFF
LINDA T.
CAPPS
LOFGREN
LEE
LOEBSACK
CAROLYN B. MALONEY
WILSON
HASTINGS
MCINTYRE
NAPOLITANO
NADLER
ENGEL
MCGOVERN
COHEN
HIMES
SERRANO
PINGREE
ELLISON
EDDIE BERNICE JOHNSON
MARKEY
DINGELL
MORAN
SHERMAN
CARSON
LARSON
FUDGE
PAYNE
CLAY
FARR
LOBIONDO
LANGEVIN
RANGEL
COOPER
SARBANES
LEWIS
JACKSON LEE
JOHNSON
YOUNG
SCHWARTZ
CONYERS
VAN HOLLEN
Topic Classifications
congressional legislation
97.4%
public health
92.2%
government oversight
80.9%
Extracted Keywords
breast cancer
breast
cancer
group health
stay
coverage
health plan
health plans
patients
issuer
hospital
insurance coverage
health insurance
inpatient
diagnosed
Forensic Analysis
PDF Metadata
- Creator
- ACOMP.exe WinVer 2.1 Mar 15 2010
- ModDate
- D:20230107130702Z
- Keywords
- dskjygpqf1prod/tshields
- Producer
- Acrobat Distiller 9.5.2 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20130419050627-04'00'
Sentiment
Polarity
Neutral
0.027
Subjectivity
37%
Objective